TAIKO PHARMACEUTICAL CO., LTD.
Manufactures OTC medicines and infection control products, specializing in GI remedies.
4574 | T
Overview
Corporate Details
- ISIN(s):
- JP3442200006
- LEI:
- Country:
- Japan
- Address:
- 吹田市内本町三丁目３４番１４号
- Website:
- https://www.seirogan.co.jp/en/
- Sector:
- Manufacturing
Description
Taiko Pharmaceutical Co., Ltd. is a pharmaceutical company that manufactures and sells over-the-counter (OTC) medicines and infection control products. The company specializes in gastrointestinal remedies, with its flagship product, Seirogan, being a long-standing treatment for conditions such as diarrhea, loose stools, and symptoms of food and water poisoning. Its product portfolio also includes other general-use pharmaceuticals and quasi-drugs. Alongside its core pharmaceutical business, Taiko Pharmaceutical is engaged in the development and marketing of sanitation and infection management solutions. The company operates on the principles of Independence, Interdependence, and Creativity, serving both domestic and international markets.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-30 08:12 |
内部統制報告書－第76期(令和3年1月1日－令和3年12月31日)
|
Japanese | ZIP • 22.1 KB | ||
| 2022-03-30 08:10 |
確認書
|
Japanese | ZIP • 8.1 KB | ||
| 2022-03-30 08:07 |
有価証券報告書－第76期(令和3年1月1日－令和3年12月31日)
|
Japanese | ZIP • 1.0 MB | ||
| 2021-11-09 07:37 |
四半期報告書－第76期第3四半期(令和3年7月1日－令和3年9月30日)
|
Japanese | ZIP • 142.4 KB | ||
| 2021-08-06 08:29 |
四半期報告書－第76期第2四半期(令和3年4月1日－令和3年6月30日)
|
Japanese | ZIP • 198.4 KB | ||
| 2021-05-07 09:38 |
四半期報告書－第76期第1四半期(令和3年1月1日－令和3年3月31日)
|
Japanese | ZIP • 145.2 KB | ||
| 2021-03-30 07:17 |
内部統制報告書－第75期(令和2年4月1日－令和2年12月31日)
|
Japanese | ZIP • 23.3 KB | ||
| 2021-03-30 07:15 |
確認書
|
Japanese | ZIP • 8.0 KB | ||
| 2021-03-30 07:12 |
有価証券報告書－第75期(令和2年4月1日－令和2年12月31日)
|
Japanese | ZIP • 978.5 KB | ||
| 2020-11-12 07:19 |
四半期報告書－第75期第2四半期(令和2年7月1日－令和2年9月30日)
|
Japanese | ZIP • 193.8 KB | ||
| 2020-08-12 08:31 |
四半期報告書－第75期第1四半期(令和2年4月1日－令和2年6月30日)
|
Japanese | ZIP • 148.7 KB | ||
| 2020-06-26 07:25 |
有価証券報告書－第74期(平成31年4月1日－令和2年3月31日)
|
Japanese | ZIP • 1.0 MB | ||
| 2020-02-10 07:17 |
四半期報告書－第74期第3四半期(令和1年10月1日－令和1年12月31日)
|
Japanese | ZIP • 144.2 KB | ||
| 2019-11-08 07:21 |
四半期報告書－第74期第2四半期(2019/07/01－2019/09/30)
|
Japanese | ZIP • 170.2 KB | ||
| 2019-08-09 08:09 |
四半期報告書－第74期第1四半期(2019/04/01－2019/06/30)
|
Japanese | ZIP • 131.6 KB |
Automate Your Workflow. Get a real-time feed of all TAIKO PHARMACEUTICAL CO., LTD. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for TAIKO PHARMACEUTICAL CO., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for TAIKO PHARMACEUTICAL CO., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
